Overview

A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus

Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
To compare short-term efficacy and safety of Exubera vs Lantus in patients with type 2 diabetes mellitus
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Treatments:
Insulin
Insulin Glargine
Insulin, Globin Zinc